← Leaderboards
Hanna Kelly Sanoff
University Of Virginia
$850,500
Attributed
$850,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $170.1K · FY2011–15$200K$150K$100K$50K$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$850,500 · 1
By mechanism
K07$850,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia
Same institution · by research overlap
- Stephanie A Guerlain$1,891,682
- Sarah J Ratcliffe$6,997,529
- Kimberly A. Kelly$7,276,942
- Jamie Zoellner$10,881,288
- Craig Thomas Parker$1,515,390
Others in their field
Top investigators on “Adverse Outcome”
- James Dennis Neaton · Northwestern University$203,539,316
- John M Lachin · George Washington University$139,991,329
- Elizabeth A Thom · George Washington University$126,101,581
- David M Nathan · Massachusetts Institute Of Technology$120,651,895
- Constance Ann Benson · University Of California, San Diego$86,364,171
- Lisa P Jacobson · Johns Hopkins University$79,976,469
Research focus
Adverse OutcomeAffectAttentionAwardBaseBay 54-9085BeneficiaryBiometryBlue CrossBlue ShieldCancer EtiologyCancer TherapyCareer DevelopmentCaringCessation Of LifeChemoembolizationCirrhosisClinically RelevantClinical TrialsCommunitiesComparativeComparative EffectivenessData CollectionAdverse Event
Grant awards (5)
Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc$170,100
K07 · FY2015 · CA · contact PI
Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc$170,100
K07 · FY2014 · CA · contact PI
Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc$170,100
K07 · FY2013 · CA · contact PI
Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc$170,100
K07 · FY2012 · CA · contact PI
Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc$170,100
K07 · FY2011 · CA · contact PI